UC
UCB S.A.
UCBJY · OTC
$121.96 +0.13% (+$0.16)
1M -5.12%
Market Cap 40.5B €
P/E Ratio 27.05x
Div. Yield 0.70%
ROE 14.18%
Bulios Fair Price
$75.78
37.9% downside
Current Price
$121.96
Undervalued Fair Value Overvalued
According to Bulios Fair Price, UCBJY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
44 /100
Fair P/E 27.05x
PEG 0.67x
EV/EBITDA 23.50x
Growth
85 /100
Growing EPS growth 52.89%
Book val. growth 6.22%
Rev. growth 10.46%
Profitability
89 /100
Strong Gross margin 71.14%
FCF margin 24.31%
Net margin 20.13%
Quality
51 /100
Average ROIC 6.93%
Asset turnover 0.41x
ROE 14.18%
Debt
91 /100
Low Debt/Equity 0.21x
Net debt/EBITDA -0.00x
Current ratio 1.38x
Stability
38 /100
Moderate Beta 0.20x
Profitable years 6
Rev. volatility 13.87%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about UCBJY
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jean-Christophe Tellier
Employees
10,117
Headquarters
Brussels
Upcoming events
25 FEB
Earnings
Upcoming earnings report